CN118754983A - A testosterone sandwich rabbit monoclonal antibody and its application - Google Patents
A testosterone sandwich rabbit monoclonal antibody and its application Download PDFInfo
- Publication number
- CN118754983A CN118754983A CN202410802927.0A CN202410802927A CN118754983A CN 118754983 A CN118754983 A CN 118754983A CN 202410802927 A CN202410802927 A CN 202410802927A CN 118754983 A CN118754983 A CN 118754983A
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- seq
- testosterone
- sequence shown
- rabbit monoclonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title claims abstract description 119
- 229960003604 testosterone Drugs 0.000 title claims abstract description 61
- 241000283973 Oryctolagus cuniculus Species 0.000 title claims abstract description 54
- 238000001514 detection method Methods 0.000 claims abstract description 39
- 101100476210 Caenorhabditis elegans rnt-1 gene Proteins 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 31
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 23
- 238000003118 sandwich ELISA Methods 0.000 claims abstract description 7
- 108091033319 polynucleotide Proteins 0.000 claims description 13
- 102000040430 polynucleotide Human genes 0.000 claims description 13
- 239000002157 polynucleotide Substances 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 239000013604 expression vector Substances 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 238000003259 recombinant expression Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000003018 immunoassay Methods 0.000 abstract description 15
- 239000000427 antigen Substances 0.000 abstract description 10
- 102000036639 antigens Human genes 0.000 abstract description 10
- 108091007433 antigens Proteins 0.000 abstract description 10
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 12
- 238000002965 ELISA Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000003098 androgen Substances 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 239000011859 microparticle Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- -1 testosterone small molecules Chemical class 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000006249 magnetic particle Substances 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000012089 stop solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000012536 storage buffer Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- 208000020576 Adrenal disease Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 206010057672 Male sexual dysfunction Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 208000006155 precocious puberty Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本申请属于免疫检测技术领域,公开了一种睾酮夹心法兔单克隆抗体及其应用。本申请提供的睾酮夹心法单克隆抗体mAb2,包含轻链可变区和重链可变区,所述轻链可变区的LCDR1包含如SEQ ID NO:1所示的氨基酸序列,LCDR2包含如SEQ ID NO:2所示的氨基酸序列,LCDR3包含如SEQ ID NO:3所示的序列;所述重链可变区的HCDR1包含如SEQ ID NO:4所示的氨基酸序列,HCDR2包含如SEQ ID NO:5所示的氨基酸序列,HCDR3包含如SEQ ID NO:6所示的序列。本申请的单克隆抗体可与睾酮复合物高特异性结合,适用于双抗夹心法免疫检测,将其应用于双抗体夹心ELISA或化学发光法制备的免疫检测试剂盒中,双抗体夹心化学发光平台检测睾酮标准抗原,检测灵敏度低于0.5ng/ml,磁化学发光法检测临床样本,在0.4‑16ng/mL样本范围内,和临床比对相关性良好。
The present application belongs to the field of immunoassay technology, and discloses a testosterone sandwich rabbit monoclonal antibody and its application. The testosterone sandwich monoclonal antibody mAb2 provided by the present application, comprising a light chain variable region and a heavy chain variable region, the LCDR1 of the light chain variable region comprises the amino acid sequence shown in SEQ ID NO:1, LCDR2 comprises the amino acid sequence shown in SEQ ID NO:2, and LCDR3 comprises the sequence shown in SEQ ID NO:3; the HCDR1 of the heavy chain variable region comprises the amino acid sequence shown in SEQ ID NO:4, HCDR2 comprises the amino acid sequence shown in SEQ ID NO:5, and HCDR3 comprises the sequence shown in SEQ ID NO:6. The monoclonal antibody of the present application can bind to the testosterone complex with high specificity, is suitable for double antibody sandwich immunoassay, is applied to the immunoassay kit prepared by double antibody sandwich ELISA or chemiluminescence, and the double antibody sandwich chemiluminescence platform detects testosterone standard antigen, and the detection sensitivity is less than 0.5ng/ml, and the magnetic chemiluminescence method detects clinical samples, within the range of 0.4-16ng/mL sample, and has good correlation with clinical comparison.
Description
技术领域Technical Field
本申请涉及免疫检测技术领域,具体涉及一种睾酮夹心法兔单克隆抗体及其应用。The present application relates to the technical field of immunoassay, and in particular to a testosterone sandwich rabbit monoclonal antibody and its application.
背景技术Background Art
睾酮是人体内最主要的雄激素,主要由睾丸间质细胞合成,肾上腺可分泌雄激素。此外,女性卵巢也可分泌少量雄激素。血液中的绝大部分睾酮可与血浆蛋白结合,仅有少数以游离形式存在。游离的睾酮才具有生物活性。睾酮的主要生理作用为促进生殖器官的发育和生长,刺激性欲,同时,促进和维持男性第二性征的发育,维持前列腺和精囊的功能和生精作用。此外,其还可促进蛋白质合成、骨骼生长以及红细胞生成。该指标可用于评估睾丸雄激素分泌功能,帮助排查男性性发育异常、睾丸肿瘤及不育症等疾病。Testosterone is the most important androgen in the human body. It is mainly synthesized by interstitial cells in the testicles, and the adrenal glands can secrete androgens. In addition, female ovaries can also secrete a small amount of androgens. Most of the testosterone in the blood can bind to plasma proteins, and only a small amount exists in free form. Only free testosterone is biologically active. The main physiological effects of testosterone are to promote the development and growth of reproductive organs, stimulate sexual desire, and at the same time, promote and maintain the development of male secondary sexual characteristics, maintain the function of the prostate and seminal vesicles and spermatogenesis. In addition, it can also promote protein synthesis, bone growth, and red blood cell production. This indicator can be used to evaluate the secretion function of testicular androgen and help rule out diseases such as abnormal male sexual development, testicular tumors, and infertility.
睾酮含量反映人体内雄性激素的正常范围,临床上常用于诊断某些内分泌疾病,如男子性功能障碍、女子性征异常、性早熟、性幼稚等。睾酮水平测定的临床意义对于女性来说非常重要。当女性血清睾酮水平降低时,通常没有明显的临床意义。然而,当睾酮水平升高时,可能与妇科疾病、肾上腺疾病、妊娠、外源性因素相关。Testosterone content reflects the normal range of male hormones in the human body and is often used clinically to diagnose certain endocrine diseases, such as male sexual dysfunction, female sexual abnormalities, precocious puberty, sexual immaturity, etc. The clinical significance of testosterone level determination is very important for women. When the serum testosterone level of women decreases, it usually has no obvious clinical significance. However, when the testosterone level increases, it may be related to gynecological diseases, adrenal diseases, pregnancy, and exogenous factors.
目前,睾酮检测的“金标准”是质谱法,但质谱法检测需要复杂且耗时的样品前处理流程以及临床对自动化高要求,难以规模应用。因此,临床上通常采用免疫检测法进行检测。免疫检测技术操作简单、检测快速,是小分子质谱检测切实可行的替代方法。由于小分子缺乏抗原表位,目前临床免疫检测普遍采用的是竞争法,竞争法检测灵敏度低,特异性不好,易出现假阳,工艺复杂。At present, the "gold standard" for testosterone detection is mass spectrometry, but mass spectrometry detection requires complex and time-consuming sample pre-treatment processes and high clinical automation requirements, making it difficult to apply on a large scale. Therefore, immunoassays are usually used in clinical testing. Immunoassay technology is simple to operate and fast to detect, and is a practical alternative to small molecule mass spectrometry detection. Because small molecules lack antigenic epitopes, competitive methods are currently commonly used in clinical immunoassays. Competitive methods have low sensitivity, poor specificity, are prone to false positives, and have complex processes.
为解决竞争法在小分子临床应用的技术难题,目前急需开发针对睾酮夹心法高特异性、高灵敏度单克隆抗体,突破传统竞争法局限,实现双抗夹心法检测睾酮至关重要。In order to solve the technical difficulties in the clinical application of the competition method in small molecules, it is urgently necessary to develop highly specific and sensitive monoclonal antibodies for the testosterone sandwich method. It is crucial to break through the limitations of the traditional competition method and realize the double antibody sandwich method for testosterone detection.
发明内容Summary of the invention
为了克服上述技术问题,本申请提供了特异性好、亲和力高的睾酮夹心法兔单克隆抗体,及其在双抗体夹心ELISA或化学发光法制备的免疫检测试剂盒中的应用,为前列腺疾病提供临床管理。In order to overcome the above technical problems, the present application provides a testosterone sandwich rabbit monoclonal antibody with good specificity and high affinity, and its application in an immunoassay kit prepared by double antibody sandwich ELISA or chemiluminescence method, to provide clinical management for prostate diseases.
第一方面,本申请提供了一种睾酮夹心法兔单克隆抗体mAb2,所述兔单克隆抗体包括轻链可变区和重链可变区,所述轻链可变区的LCDR1包含如SEQ ID NO:1所示的氨基酸序列,LCDR2包含如SEQ ID NO:2所示的氨基酸序列,LCDR3包含如SEQ ID NO:3所示的序列;所述重链可变区的HCDR1包含如SEQ ID NO:4所示的氨基酸序列,HCDR2包含如SEQ ID NO:5所示的氨基酸序列,HCDR3包含如SEQ ID NO:6所示的序列。In the first aspect, the present application provides a testosterone sandwich rabbit monoclonal antibody mAb2, wherein the rabbit monoclonal antibody comprises a light chain variable region and a heavy chain variable region, wherein the LCDR1 of the light chain variable region comprises the amino acid sequence shown in SEQ ID NO:1, the LCDR2 comprises the amino acid sequence shown in SEQ ID NO:2, and the LCDR3 comprises the sequence shown in SEQ ID NO:3; the HCDR1 of the heavy chain variable region comprises the amino acid sequence shown in SEQ ID NO:4, the HCDR2 comprises the amino acid sequence shown in SEQ ID NO:5, and the HCDR3 comprises the sequence shown in SEQ ID NO:6.
进一步地,所述轻链可变区包含如SEQ ID NO:7所示的氨基酸序列,VL全长为110个氨基酸,其FR的4个结构域氨基酸数分别为26、16、36和10,LCDR的3个结构域氨基酸数分别为8、3和11,LCDR1、LCDR2和LCDR3的区域相应地分别为27aa-34aa,51aa-53aa和90aa-100aa,其氨基酸序列分别:QSVYSRNW(SEQ ID NO.1)、KAS(SEQ ID NO.2)、AGGYSGNIYYA(SEQID NO.3)。Further, the light chain variable region comprises the amino acid sequence shown in SEQ ID NO:7, the full length of VL is 110 amino acids, the number of amino acids in the four domains of FR are 26, 16, 36 and 10 respectively, the number of amino acids in the three domains of LCDR are 8, 3 and 11 respectively, the regions of LCDR1, LCDR2 and LCDR3 are 27aa-34aa, 51aa-53aa and 90aa-100aa respectively, and their amino acid sequences are: QSVYSRNW (SEQ ID NO.1), KAS (SEQ ID NO.2), AGGYSGNIYYA (SEQID NO.3).
进一步地,所述重链可变区包含如SEQ ID NO:8所示的氨基酸序列,VH全长为120个氨基酸,其FR的4个结构域氨基酸数分别为25、16、38和11,HCDR的3个结构域氨基酸数分别为8、7和15,HCDR1、HCDR2和HCDR3分别为26aa-33aa,50aa-56aa和95aa-109aa,其氨基酸序列分别为GFSLSSYA(SEQ ID NO.4)、ISSSGST(SEQ ID NO.5)、ARGVSYDDYGDPFNL(SEQ IDNO.6)。Further, the heavy chain variable region comprises the amino acid sequence shown in SEQ ID NO:8, the full length of VH is 120 amino acids, the number of amino acids in the four domains of FR are 25, 16, 38 and 11 respectively, the number of amino acids in the three domains of HCDR are 8, 7 and 15 respectively, HCDR1, HCDR2 and HCDR3 are 26aa-33aa, 50aa-56aa and 95aa-109aa respectively, and their amino acid sequences are GFSLSSYA (SEQ ID NO.4), ISSSGST (SEQ ID NO.5), ARGVSYDDYGDPFNL (SEQ IDNO.6), respectively.
采用上述技术方案,本申请的睾酮夹心法兔单克隆抗体mAb2可以与睾酮高特异性结合,并具有高亲和力,其亲和常数Ka可达6.2×108L/mol。By adopting the above technical scheme, the testosterone sandwich rabbit monoclonal antibody mAb2 of the present application can bind to testosterone with high specificity and high affinity, and its affinity constant Ka can reach 6.2×10 8 L/mol.
另一方面,本申请还提供了分离的多核苷酸,所述分离的多核苷酸编码含有所述的兔单克隆抗体mAb2。On the other hand, the present application also provides an isolated polynucleotide, which encodes the rabbit monoclonal antibody mAb2.
另一方面,本申请还提供了核酸构建体,所述核酸构建体含有所述的多核苷酸,优选地,所述多核苷酸可以操作地连接至少一个表达调控元件On the other hand, the present application also provides a nucleic acid construct, wherein the nucleic acid construct contains the polynucleotide, preferably, the polynucleotide can be operably linked to at least one expression control element
另一方面,本申请还提供了重组表达载体,所述重组表达载体含有所述的多核苷酸,或所述的核酸构建体。On the other hand, the present application also provides a recombinant expression vector, which contains the polynucleotide or the nucleic acid construct.
另一方面,本申请还提供了宿主细胞,所述宿主细胞含有所述的多核苷酸,或所述的核酸构建体,或所述的重组表达载体。On the other hand, the present application also provides a host cell, which contains the polynucleotide, or the nucleic acid construct, or the recombinant expression vector.
另一方面,本申请还提供了所述的兔单克隆抗体mAb2、所述的多核苷酸、所述的核酸构建体、所述的重组表达载体和/或所述的宿主细胞在制备用于检测睾酮的检测试剂或试剂盒中的应用。On the other hand, the present application also provides the use of the rabbit monoclonal antibody mAb2, the polynucleotide, the nucleic acid construct, the recombinant expression vector and/or the host cell in the preparation of a detection reagent or kit for detecting testosterone.
另一方面,本申请还提供了一种用于检测睾酮的检测试剂或检测试剂盒,所述检测试剂或检测试剂盒含有所述的兔单克隆抗体mAb2。On the other hand, the present application also provides a detection reagent or a detection kit for detecting testosterone, wherein the detection reagent or the detection kit contains the rabbit monoclonal antibody mAb2.
进一步地,所述检测试剂盒为双抗体夹心ELISA或化学发光法制备的免疫检测试剂盒,所述兔单克隆抗体mAb2为检测抗体。Furthermore, the detection kit is an immunoassay kit prepared by double antibody sandwich ELISA or chemiluminescence method, and the rabbit monoclonal antibody mAb2 is the detection antibody.
另一方面,本申请还提供了一种制备所述兔单克隆抗体mAb2的方法,所述方法包括,在适合于所述兔单克隆抗体mAb2表达的条件下,使用所述的宿主细胞表达所述兔单克隆抗体mAb2,并从所述宿主细胞的培养物中回收所表达的单克隆抗体。On the other hand, the present application also provides a method for preparing the rabbit monoclonal antibody mAb2, which comprises expressing the rabbit monoclonal antibody mAb2 using the host cell under conditions suitable for the expression of the rabbit monoclonal antibody mAb2, and recovering the expressed monoclonal antibody from the culture of the host cell.
相对于现有技术而言,本申请的睾酮夹心法兔单克隆抗体可以与睾酮高特异性结合,并具有高亲和力,其亲和常数Ka可达6.2×108L/mol。本申请的睾酮夹心法兔单克隆抗体还可以制备成检测睾酮的各种免疫检测试剂盒,尤其是,应用于双抗体夹心ELISA或化学发光法制备的免疫检测试剂盒中。双抗体夹心化学发光平台检测睾酮标准抗原,检测灵敏度低于0.5ng/ml,磁化学发光法检测临床样本,在0.4-16ng/mL样本范围内,和R临床比对相关性良好。Compared with the prior art, the testosterone sandwich rabbit monoclonal antibody of the present application can bind to testosterone with high specificity and high affinity, and its affinity constant Ka can reach 6.2×10 8 L/mol. The testosterone sandwich rabbit monoclonal antibody of the present application can also be prepared into various immunoassay kits for detecting testosterone, especially, it can be used in immunoassay kits prepared by double antibody sandwich ELISA or chemiluminescence method. The double antibody sandwich chemiluminescence platform detects testosterone standard antigen with a detection sensitivity of less than 0.5ng/ml. The magnetic chemiluminescence method detects clinical samples with a sample range of 0.4-16ng/mL, and has a good correlation with the R clinical comparison.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为mAb2重链和轻链全长扩增产物的电泳图,M为DNA分子量Marker。FIG1 is an electrophoresis diagram of the full-length amplified products of mAb2 heavy chain and light chain, where M is a DNA molecular weight marker.
图2为mAb2夹心ELISA法检测交叉蛋白以及目的抗原样本,纵坐标为检测的OD值。FIG2 shows the detection of cross-protein and target antigen samples by the mAb2 sandwich ELISA method, and the ordinate is the OD value of the detection.
图3为mAb2磁微粒化学发光法检测睾酮标准抗原,横坐标为睾酮标准抗原浓度(ng/ml),纵坐标为检测的发光值。标准曲线的R2=0.9964,线性检测范围0.4-16n/mL,推出样品浓度计算公式:y=162200x-51092。Figure 3 shows the mAb2 magnetic microparticle chemiluminescence method for testing testosterone standard antigen, the horizontal axis is the testosterone standard antigen concentration (ng/ml), and the vertical axis is the luminescence value of the test. The R 2 of the standard curve is 0.9964, the linear detection range is 0.4-16n/mL, and the sample concentration calculation formula is: y=162200x-51092.
图4为mAb2磁微粒化学发光法检测临床样本,横坐标为临床样本睾酮浓度(ng/ml),纵坐标为检测的发光值。标准曲线的R2=0.9676,线性检测范围0.4-16n/mL,推出样品浓度计算公式:y=27870x+61136。Figure 4 shows the mAb2 magnetic microparticle chemiluminescence method for clinical samples, with the horizontal axis representing the testosterone concentration of clinical samples (ng/ml) and the vertical axis representing the luminescence value of the test. The R 2 of the standard curve is 0.9676, with a linear detection range of 0.4-16 n/mL, and the formula for calculating the sample concentration is: y=27870x+61136.
具体实施方式DETAILED DESCRIPTION
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件、实验室手册中所述的条件或按照制造厂商所建议的条件。The present invention is further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples without specifying specific conditions are usually carried out according to conventional conditions, conditions described in laboratory manuals or conditions recommended by manufacturers.
实施例1睾酮夹心法兔单克隆抗体的制备Example 1 Preparation of testosterone sandwich rabbit monoclonal antibody
1)免疫原的制备1) Preparation of immunogen
制备睾酮复合物,免疫原纯度在90%以上,达到了制备单抗的纯度要求。The testosterone complex was prepared with an immunogen purity of more than 90%, meeting the purity requirement for preparing monoclonal antibodies.
2)动物免疫2) Animal immunization
上述制备的睾酮复合物以1:1的体积比用完全弗氏佐剂乳化,采用皮下注射方法免疫2kg左右的新西兰大白兔,免疫剂量为800μg/只,间隔两周后进行第二次免疫,以不完全弗氏佐剂以1:1的体积比乳化,免疫剂量为400μg/只。免疫两次后取尾血以ELISA法梯度稀释测定血清效价;依据ELISA效价128000时的OD450大于1.0为标准,根据结果判定是否收集PBMCs或是继续免疫,选取抗体效价最高的兔子进行PBMCs收集。The testosterone complex prepared above was emulsified with complete Freund's adjuvant at a volume ratio of 1:1, and New Zealand white rabbits weighing about 2 kg were immunized by subcutaneous injection, with an immunization dose of 800 μg/rabbit. A second immunization was performed two weeks later, emulsified with incomplete Freund's adjuvant at a volume ratio of 1:1, with an immunization dose of 400 μg/rabbit. After two immunizations, tail blood was collected to determine the serum titer by gradient dilution using the ELISA method; based on the OD450 greater than 1.0 when the ELISA titer was 128,000, it was determined whether to collect PBMCs or continue immunization based on the results, and the rabbit with the highest antibody titer was selected for PBMCs collection.
3)PBMCs分离、特异性B细胞分选、克隆重组3) PBMCs isolation, specific B cell sorting, and cloning recombination
将兔仰卧固定在手术台上,将心脏部位被毛减掉,用酒精消毒皮肤,选择心搏最明显处用50ml注射器穿刺,针头刺入心脏后即有血液涌入注射器,取得所需血量后迅速将针头拔出,将注射器中的全血转入无菌50ml管中,与等量的PBS混匀后逐滴缓慢的加入到淋巴细胞分离液上方,室温400×g离心30分钟,离心后,液面由上至下分为四层:黄色血浆层、白色薄膜层即单个核细胞层、分离液层及红细胞层,小心吸取单个核细胞层并用PBS洗涤去除血小板和淋巴细胞分离液后即可获得兔PBMCs。The rabbit was fixed on the operating table in supine position, the hair at the heart area was trimmed, the skin was disinfected with alcohol, and the most obvious heartbeat was selected for puncture with a 50ml syringe. Blood flowed into the syringe after the needle pierced the heart. After obtaining the required amount of blood, the needle was quickly pulled out, and the whole blood in the syringe was transferred to a sterile 50ml tube, mixed with an equal amount of PBS, and then slowly added drop by drop to the lymphocyte separation solution. Centrifuged at room temperature at 400×g for 30 minutes. After centrifugation, the liquid surface was divided into four layers from top to bottom: yellow plasma layer, white film layer, i.e., mononuclear cell layer, separation solution layer and red blood cell layer. The mononuclear cell layer was carefully aspirated and washed with PBS to remove platelets and lymphocyte separation solution to obtain rabbit PBMCs.
从兔PBMCs中继续分选抗原特异性的B细胞进行培养,培养后的B细胞上清用抗原包被的ELISA板筛选阳性克隆。阳性克隆的细胞收集裂解后提取RNA并反转录成cDNA,天然配对的兔单克隆抗体轻链、重链全长序列从对应阳性克隆的cDNA中被扩增出来,通过克隆重组方法构建兔单克隆抗体表达载体,并经测序确定序列,扩增的全长PCR产物结果如图1。Antigen-specific B cells were further sorted from rabbit PBMCs for culture, and the supernatant of cultured B cells was screened for positive clones using an antigen-coated ELISA plate. The cells of the positive clones were collected and lysed, and RNA was extracted and reverse transcribed into cDNA. The full-length sequences of the naturally paired rabbit monoclonal antibody light chain and heavy chain were amplified from the cDNA of the corresponding positive clones. The rabbit monoclonal antibody expression vector was constructed by cloning and recombination methods, and the sequence was determined by sequencing. The results of the amplified full-length PCR product are shown in Figure 1.
4)单克隆抗体的制备和纯化4) Preparation and purification of monoclonal antibodies
为了获得多株识别睾酮小分子的兔单克隆抗体,将兔单克隆抗体重链、轻链基因装载在表达载体上,将质粒转染KEK293细胞,转染120-144小时获得培养上清中含有重组的识别睾酮小分子的兔单克隆抗体。收取细胞悬液,离心取上清,亲和层析法进行抗体纯化。以BCA法测定纯化后的单抗浓度,再分装、冻干,将纯化后的抗体命名为兔单克隆抗体mAb2。In order to obtain multiple rabbit monoclonal antibodies that recognize testosterone small molecules, the heavy chain and light chain genes of rabbit monoclonal antibodies were loaded on the expression vector, and the plasmid was transfected into KEK293 cells. The culture supernatant was obtained after 120-144 hours of transfection to obtain recombinant rabbit monoclonal antibodies that recognize testosterone small molecules. The cell suspension was collected, the supernatant was centrifuged, and the antibody was purified by affinity chromatography. The concentration of the purified monoclonal antibody was determined by the BCA method, and then the purified antibody was packaged and lyophilized. The purified antibody was named rabbit monoclonal antibody mAb2.
实施例2睾酮夹心法兔单克隆抗体鉴定Example 2 Testosterone Sandwich Rabbit Monoclonal Antibody Identification
1)兔单克隆抗体的特异性鉴定1) Specificity identification of rabbit monoclonal antibodies
采用间接ELSA法检测。以交叉蛋白、睾酮复合物抗原包被酶标板,浓度为1μg/ml,4℃过夜,以含1%BSA的PBST封闭酶标板,加104倍稀释的纯化后兔单克隆抗体,37℃反应50min,PBST洗板3次,加HRP-羊抗兔Ig二抗,37℃反应50min,PBST洗板5次,加TMB显色10min,加终止液,酶标仪测A450。Indirect ELSA method was used for detection. The ELISA plate was coated with cross protein and testosterone complex antigen at a concentration of 1 μg/ml, overnight at 4°C, blocked with PBST containing 1% BSA, added with 10 4- fold diluted purified rabbit monoclonal antibody, reacted at 37°C for 50 min, washed 3 times with PBST, added with HRP-goat anti-rabbit Ig secondary antibody, reacted at 37°C for 50 min, washed 5 times with PBST, added with TMB color development for 10 min, added with stop solution, and measured A450 with an ELISA reader.
图2结果显示,交叉蛋白与兔单克隆抗体mAb2抗体反应呈阴性,OD450均小于0.2;睾酮复合物与mAb2抗体反应呈阳性,OD值远高于交叉蛋白,说明本申请的睾酮夹心法兔单克隆抗体特异性识别睾酮复合物。The results in Figure 2 show that the cross protein reacts negatively with the rabbit monoclonal antibody mAb2, with OD450 less than 0.2; the testosterone complex reacts positively with the mAb2 antibody, with an OD value much higher than that of the cross protein, indicating that the testosterone sandwich method rabbit monoclonal antibody of the present application specifically recognizes the testosterone complex.
2)兔单克隆抗体的亲和常数测定2) Determination of affinity constant of rabbit monoclonal antibody
采用非竞争ELISA法测定亲和常数(Ka)。The affinity constant (Ka) was determined by non-competitive ELISA.
包被:用碳酸盐缓冲液稀释抗原至浓度为1、0.5、0.1、0.05μg/mL,按照100μL/孔加到96孔酶标板分别包被,4℃孵育24h;Coating: Dilute the antigen with carbonate buffer to a concentration of 1, 0.5, 0.1, and 0.05 μg/mL, add 100 μL/well to a 96-well ELISA plate for coating, and incubate at 4°C for 24 h;
封闭:用PBST洗板4次,按照200μL/孔加入BSA溶液,37℃孵育2h;Blocking: Wash the plate 4 times with PBST, add BSA solution at 200 μL/well, and incubate at 37°C for 2 h;
加单抗:用PBST洗板4次,用碳酸盐缓冲液将兔单抗以100μg/mL开始倍比稀释,每孔加入100μL,37℃孵育2h;Adding monoclonal antibody: Wash the plate 4 times with PBST, dilute the rabbit monoclonal antibody starting at 100 μg/mL with carbonate buffer, add 100 μL to each well, and incubate at 37°C for 2 h;
加酶标二抗:用PBST洗板4次,每孔加入100μL的l:10000倍稀释的HRP酶标记的羊抗兔Ig二抗,37℃放置30min;Add enzyme-labeled secondary antibody: wash the plate 4 times with PBST, add 100 μL of 1:10000-fold diluted HRP enzyme-labeled goat anti-rabbit Ig secondary antibody to each well, and place at 37°C for 30 min;
显色及终止:用PBST洗板4次,每孔加底物显色液100μL,37℃避光反应15min;每孔加入50μL 1.0mol/L的H2SO4终止液,终止反应;Color development and termination: Wash the plate 4 times with PBST, add 100 μL of substrate color development solution to each well, and react at 37°C in the dark for 15 min; add 50 μL of 1.0 mol/L H 2 SO 4 stop solution to each well to terminate the reaction;
检测:测定波长为450nm处的吸光度值(A450nm)。Detection: Measure the absorbance value at a wavelength of 450nm (A450nm).
以抗体浓度的对数为横坐标,以OD值为纵坐标,绘制S型曲线,经计算,睾酮夹心法单克隆抗体mAb2的亲和常数Ka=6.2×108L/mol。An S-shaped curve was drawn with the logarithm of the antibody concentration as the abscissa and the OD value as the ordinate. After calculation, the affinity constant Ka of the testosterone sandwich monoclonal antibody mAb2 was 6.2×10 8 L/mol.
3)夹心法抗体配对3) Sandwich antibody pairing
为了挑选包被抗体和检测抗体的最佳组合,将睾酮复合物抗体包被酶标板,4℃过夜。第二天取出酶标板,PBST洗涤一次,1%BSA溶液37℃封闭2小时,PBST洗涤3次;每孔加入睾酮复合物100μl,浓度为20ng/ml,37℃孵育1小时;孵育完成后取出酶标板,PBST洗涤3次,分别加入HRP标记的兔单克隆抗体mAb2作为检测抗体,37℃孵育1小时。PBST洗涤5次,加入TMB底物,37℃显色10min。取出后加终止液,在酶标仪上测定OD450读数。根据样品的OD值与阴性对照的背景值,选出最为理想的抗体对,配对筛选结果见表1。In order to select the best combination of coating antibody and detection antibody, the testosterone complex antibody was coated on the ELISA plate at 4°C overnight. The next day, the ELISA plate was removed, washed once with PBST, blocked with 1% BSA solution at 37°C for 2 hours, and washed 3 times with PBST; 100 μl of testosterone complex was added to each well at a concentration of 20 ng/ml, and incubated at 37°C for 1 hour; after the incubation, the ELISA plate was removed, washed 3 times with PBST, and HRP-labeled rabbit monoclonal antibody mAb2 was added as the detection antibody, respectively, and incubated at 37°C for 1 hour. Washed 5 times with PBST, TMB substrate was added, and color was developed at 37°C for 10 minutes. After removal, stop solution was added and OD450 reading was measured on the ELISA instrument. According to the OD value of the sample and the background value of the negative control, the most ideal antibody pair was selected. The paired screening results are shown in Table 1.
表1抗体配对实验筛选结果Table 1 Antibody pairing experiment screening results
可见,本申请涉及的抗体mAb2用于夹心法检测最佳。It can be seen that the antibody mAb2 involved in the present application is best used for sandwich detection.
实施例3兔单克隆抗体可变区基因与氨基酸序列分析Example 3 Analysis of variable region genes and amino acid sequences of rabbit monoclonal antibodies
以抗体的重组质粒为DNA模板,根据模板上轻链及重链5'端载体序列设计轻链可变区及重链可变区测序引物,采用测序仪ABI 3730进行测序。经测序获得兔单克隆抗体轻链及重链可变区核苷酸序列。The recombinant plasmid of the antibody was used as a DNA template, and the sequencing primers for the light chain variable region and the heavy chain variable region were designed according to the vector sequences at the 5' end of the light chain and heavy chain on the template, and the sequencing was performed using a sequencer ABI 3730. The nucleotide sequences of the light chain and heavy chain variable regions of the rabbit monoclonal antibody were obtained by sequencing.
利用互联网,在http://www.imgt.org上使用IMGT/V-QUEST分析软件,分别将轻链可变区与重链可变区的核苷酸序列进行测序结果数据分析,兔单克隆抗体mAb2的轻链可变区氨基酸序列如SEQ ID NO.7示,重链可变区氨基酸序列如SEQ ID NO.8所示。VL全长为110个氨基酸,其FR的4个结构域氨基酸数分别为26、16、36和10,LCDR的3个结构域氨基酸数分别为8、3和11,LCDR1、LCDR2和LCDR3的区域相应地分别为27aa-34aa,51aa-53aa和90aa-100aa,其氨基酸序列分别:QSVYSRNW(SEQ ID NO.1)、KAS(SEQ ID NO.2)、AGGYSGNIYYA(SEQID NO.3);VH全长为120个氨基酸,其FR的4个结构域氨基酸数分别为25、16、38和11,HCDR的3个结构域氨基酸数分别为8、7和15,HCDR1、HCDR2和HCDR3分别为26aa-33aa,50aa-56aa和95aa-109aa,其氨基酸序列分别为GFSLSSYA(SEQ ID NO.4)、ISSSGST(SEQ ID NO.5)、ARGVSYDDYGDPFNL(SEQ ID NO.6)。The nucleotide sequences of the light chain variable region and the heavy chain variable region were sequenced and analyzed using the IMGT/V-QUEST analysis software on the Internet at http://www.imgt.org. The amino acid sequence of the light chain variable region of the rabbit monoclonal antibody mAb2 is shown in SEQ ID NO.7, and the amino acid sequence of the heavy chain variable region is shown in SEQ ID NO.8. The total length of VL is 110 amino acids, the amino acid numbers of its four domains of FR are 26, 16, 36 and 10 respectively, the amino acid numbers of its three domains of LCDR are 8, 3 and 11 respectively, the regions of LCDR1, LCDR2 and LCDR3 are 27aa-34aa, 51aa-53aa and 90aa-100aa respectively, and their amino acid sequences are: QSVYSRNW (SEQ ID NO.1), KAS (SEQ ID NO.2), AGGYSGNIYYA (SEQID NO.3); the total length of VH is 120 amino acids, the amino acid numbers of its four domains of FR are 25, 16, 38 and 11 respectively, the amino acid numbers of its three domains of HCDR are 8, 7 and 15 respectively, the regions of HCDR1, HCDR2 and HCDR3 are 26aa-33aa, 50aa-56aa and 95aa-109aa respectively, and their amino acid sequences are: GFSLSSYA (SEQ ID NO.4). NO.4), ISSSGST (SEQ ID NO.5), ARGVSYDDYGDPFNL (SEQ ID NO.6).
实施例4睾酮夹心法兔单克隆抗体用于磁微粒化学发光免疫检测Example 4 Testosterone sandwich rabbit monoclonal antibody for magnetic microparticle chemiluminescent immunoassay
一、检测原理与方法1. Detection principles and methods
采用基于双抗体夹心法原理的磁微粒化学发光免疫检测技术。生物素标记睾酮抗体,将生物素化的抗体与SA磁珠进行固定,ALP偶联睾酮复合物兔单克隆抗体,同时将睾酮、ALP底物及相应buffer组分放置到科斯迈全自动磁微粒化学发光仪上,设置仪器程序进行检测。依据发光值信噪比大于2.0判读结果为阳性。发光值的大小反映了结合的酶标抗体的量,它与标本中睾酮的浓度成正比。根据所测定的标准品的发光值绘制标准曲线,待测标本中的睾酮浓度值即可从标准曲线上获得。检测结果见图3。The magnetic particle chemiluminescence immunoassay technology based on the principle of double antibody sandwich method was used. Testosterone antibody was labeled with biotin, and the biotinylated antibody was fixed to SA magnetic beads, ALP was coupled to testosterone complex rabbit monoclonal antibody, and testosterone, ALP substrate and corresponding buffer components were placed on the Cosma automatic magnetic particle chemiluminometer, and the instrument program was set for detection. The result was judged to be positive based on the luminescence value signal-to-noise ratio greater than 2.0. The size of the luminescence value reflects the amount of bound enzyme-labeled antibody, which is proportional to the concentration of testosterone in the sample. A standard curve was drawn according to the luminescence value of the measured standard, and the testosterone concentration value in the sample to be tested can be obtained from the standard curve. The test results are shown in Figure 3.
二、检测睾酮的磁微粒化学发光检测试剂盒组成2. Composition of the magnetic particle chemiluminescence detection kit for testosterone detection
1.SA磁珠结合生物素-睾酮抗体:取50μl磁珠到0.5ml离心管中,置于磁力架上,1min后移除上清液;用0.5ml抗体稀释液洗涤磁珠3次;加入一定量的生物素标记的睾酮抗体室温旋转混合60min;进行磁性分离后重悬于磁性保存缓冲液,工作浓度0.5mg/ml。1. SA magnetic beads combined with biotin-testosterone antibody: take 50μl magnetic beads into a 0.5ml centrifuge tube, place it on a magnetic rack, and remove the supernatant after 1 minute; wash the magnetic beads 3 times with 0.5ml antibody diluent; add a certain amount of biotin-labeled testosterone antibody and rotate and mix at room temperature for 60 minutes; after magnetic separation, resuspend in magnetic storage buffer with a working concentration of 0.5mg/ml.
2.mAb2偶联ALP:首先使用2-IT还原抗体mAb2;其次进行ALP-SMCC中间物形成,最后进行ALP-SMCC与还原抗体偶联。偶联结束后使用ALP保存缓冲液稀释到工作浓度。2. mAb2 coupled with ALP: First, use 2-IT to reduce the antibody mAb2; second, form the ALP-SMCC intermediate, and finally couple ALP-SMCC with the reduced antibody. After the coupling is completed, use ALP storage buffer to dilute to the working concentration.
3.洗涤缓冲液为常规的pH7.4的PBST,含0.05% Proclin300,配制成20倍浓缩液。3. The washing buffer is conventional PBST at pH 7.4, containing 0.05% Proclin 300, and prepared into a 20-fold concentrated solution.
4.化学发光显色液购于爱维德生物。4. Chemiluminescent colorimetric solution was purchased from Avid Biotechnology.
5.样本稀释液含1%BSA、0.05%Proclin 300的PBST,过滤除菌。5. The sample diluent contains 1% BSA, 0.05% Proclin 300 in PBST, which is sterilized by filtration.
6.标准品睾酮小分子,以含1%BSA、5%蔗糖、10%甘油、0.05% Proclin300的PBS为稀释液,将样品稀释为5μg/ml,过滤除菌,无菌分装。6. Standard testosterone small molecule, using PBS containing 1% BSA, 5% sucrose, 10% glycerol, 0.05% Proclin300 as diluent, dilute the sample to 5 μg/ml, filter sterilize, and aseptically package.
三、对睾酮临床样本的检测3. Testing of clinical testosterone samples
处理不同睾酮浓度的临床样本,以睾酮抗体为包被抗体、mAb2抗体为检测抗体,用上述检测方法检测不同浓度的临床样本,检测结果见图4。Clinical samples with different testosterone concentrations were processed, testosterone antibody was used as coating antibody, mAb2 antibody was used as detection antibody, and the above detection method was used to detect clinical samples with different concentrations. The detection results are shown in Figure 4.
根据结果数据,本申请所述的兔单克隆抗体用于磁微粒化学发光免疫检测试剂,在0.4-16ng/mL样本范围内,和临床比对相关性良好。According to the result data, the rabbit monoclonal antibody described in the present application is used for magnetic microparticle chemiluminescent immunoassay reagent, and has good correlation with clinical comparison within the sample range of 0.4-16 ng/mL.
综上,将本申请的睾酮夹心法兔单克隆抗体mAb2应用于双抗体夹心ELISA或化学发光法制备的免疫检测试剂盒中,双抗体夹心化学发光平台检测睾酮标准抗原,检测灵敏度低于0.5ng/ml,磁化学发光法检测临床样本,在0.4-16ng/mL样本范围内,其临床复合率>0.95,明显高于传统竞争检测方法,且工艺简单,突破了传统竞争法的限制。In summary, the testosterone sandwich rabbit monoclonal antibody mAb2 of the present application is applied to the immunoassay kit prepared by the double antibody sandwich ELISA or chemiluminescence method. The double antibody sandwich chemiluminescence platform detects the testosterone standard antigen with a detection sensitivity of less than 0.5 ng/ml. The magnetic chemiluminescence method detects clinical samples with a clinical composite rate of >0.95 within the sample range of 0.4-16 ng/mL, which is significantly higher than the traditional competitive detection method. The process is simple, breaking through the limitations of the traditional competitive method.
本具体实施例仅仅是对本申请的解释,其并不是对本申请的限制,本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改,但只要在本申请的权利要求范围内都受到专利法的保护。This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed. However, as long as it is within the scope of the claims of the present application, it shall be protected by the patent law.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410802927.0A CN118754983A (en) | 2024-06-20 | 2024-06-20 | A testosterone sandwich rabbit monoclonal antibody and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410802927.0A CN118754983A (en) | 2024-06-20 | 2024-06-20 | A testosterone sandwich rabbit monoclonal antibody and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118754983A true CN118754983A (en) | 2024-10-11 |
Family
ID=92941186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410802927.0A Pending CN118754983A (en) | 2024-06-20 | 2024-06-20 | A testosterone sandwich rabbit monoclonal antibody and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118754983A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118772273A (en) * | 2024-08-15 | 2024-10-15 | 无锡傲锐东源生物科技有限公司 | A testosterone sandwich rabbit monoclonal antibody mAb1 and its application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008009960A2 (en) * | 2006-07-21 | 2008-01-24 | Haptogen Ltd | Anti-testosterone antibodies |
CN104558174A (en) * | 2015-01-29 | 2015-04-29 | 东南大学 | Testosterone-orientated specific nano-antibody and application thereof |
CN104558171A (en) * | 2014-12-26 | 2015-04-29 | 华中农业大学 | Monoclonal antibody, enzyme linked immunosorbent assay and kit for detecting methyltestosterone |
CN116041510A (en) * | 2023-01-06 | 2023-05-02 | 郑州伊美诺生物技术有限公司 | Preparation and application of testosterone monoclonal antibody |
-
2024
- 2024-06-20 CN CN202410802927.0A patent/CN118754983A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008009960A2 (en) * | 2006-07-21 | 2008-01-24 | Haptogen Ltd | Anti-testosterone antibodies |
CN104558171A (en) * | 2014-12-26 | 2015-04-29 | 华中农业大学 | Monoclonal antibody, enzyme linked immunosorbent assay and kit for detecting methyltestosterone |
CN104558174A (en) * | 2015-01-29 | 2015-04-29 | 东南大学 | Testosterone-orientated specific nano-antibody and application thereof |
CN116041510A (en) * | 2023-01-06 | 2023-05-02 | 郑州伊美诺生物技术有限公司 | Preparation and application of testosterone monoclonal antibody |
Non-Patent Citations (2)
Title |
---|
李超英;姜金庆;李凤云;杨金明;刘明成;吴世秀;: "睾酮单克隆杂交瘤细胞株的筛选及性能鉴定", 贵州农业科学, no. 06, 15 June 2012 (2012-06-15) * |
王德芝;张春明;杨福军;陈冀莹;秦丽莉;金月英;韩佩珍;: "血清睾酮酶联免疫吸附分析试剂盒的研制", 中国预防医学杂志, no. 02, 20 April 2006 (2006-04-20) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118772273A (en) * | 2024-08-15 | 2024-10-15 | 无锡傲锐东源生物科技有限公司 | A testosterone sandwich rabbit monoclonal antibody mAb1 and its application |
CN118772273B (en) * | 2024-08-15 | 2025-03-07 | 无锡傲锐东源生物科技有限公司 | Testosterone sandwich method rabbit monoclonal antibody mAb1 and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106432508B (en) | A kind of PLA2R THSD7A fusion proteins and its application and kit | |
WO2016011852A1 (en) | Bladder tumor-associated antigen detection kit | |
US20110165697A1 (en) | Monoclonal antibodies against osteopontin | |
CN117624351B (en) | Anti-human phosphorylated tau181 rabbit monoclonal antibody and application thereof | |
CN118772273A (en) | A testosterone sandwich rabbit monoclonal antibody mAb1 and its application | |
CN118754983A (en) | A testosterone sandwich rabbit monoclonal antibody and its application | |
CN111308085A (en) | A kind of high-sensitivity cardiac troponin I detection method and kit | |
WO2024041493A1 (en) | Method and kit for detecting monkeypox virus | |
CN102585005A (en) | Monoclonal antibody and ELLSA (Enzyme Linked Immunosorbent Assay) method for detection of methyl-3-quinoxaline-2-carboxylic acid (MQCA), and kit | |
CN118562011A (en) | Antibody, antibody composition and application of rat IgG | |
CN108558718A (en) | Florfenicol and florfenicol amine antigen, antibody and its enzyme-linked immune analytic method is detected simultaneously | |
CN113956355B (en) | Anti-human Brain Natriuretic Peptide (BNP) rabbit monoclonal antibody and application thereof | |
CN118063608B (en) | Monoclonal antibody for triiodothyronine, detection reagent based on monoclonal antibody and application of monoclonal antibody | |
CN116925218B (en) | Antibody of small heat shock protein HSPB1, antibody composition, hybridoma cell strain and application thereof | |
CN116925219B (en) | Antibody of small heat shock protein HSPB1, hybridoma cell strain and application thereof | |
CN113912719B (en) | Monoclonal antibody for detecting mouse interleukin 6 and preparation method and application thereof | |
CN114295829B (en) | Novel coronavirus antigen and total antibody combined detection kit and detection method | |
CN106244559B (en) | A hybridoma cell line secreting anti-human IL-37b monoclonal antibody, anti-human IL-37b monoclonal antibody and application thereof | |
CN104830805B (en) | Anti-human Clonorchiasis Sinensis monoclonal antibody hybridoma and its monoclonal antibody and application | |
CN114686443B (en) | Hybridoma cell, antithrombotic regulatory protein monoclonal antibody, preparation method and application thereof | |
CN119119265A (en) | A T3 sandwich rabbit monoclonal antibody mAb3 and its application | |
CN114686444B (en) | Hybridoma cell, antithrombotic regulatory protein monoclonal antibody, preparation method and application thereof | |
CN111458522A (en) | Detection reagent and kit for detecting natural antibody of plasma interleukin6 and application of detection reagent and kit | |
CN119192368B (en) | Monoclonal antibody or antigen-binding fragment thereof for detecting folic acid and its binding protein complex, preparation method and application thereof | |
CN117903305B (en) | Monoclonal antibody against estradiol, detection reagent based on monoclonal antibody and application of monoclonal antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |